Table 4.
Definition of progression | Variable | Cervical spine | Lumbar spine | ||||
OR | 95% CI | P value | OR | 95% CI | P value | ||
≥2 mSASSS units | Male sex (total effect) | 2.57 | 1.23 to 5.38 | 0.01 | 2.23 | 1.14 to 4.40 | 0.02 |
TNFi use prior to X-ray interval | 0.65 | 0.39 to 1.08 | 0.10 | 0.66 | 0.40 to 1.11 | 0.12 | |
Length of the X-ray interval (+ 1 year) | 1.04 | 0.52 to 2.07 | 0.91 | 1.16 | 0.58 to 2.32 | 0.67 | |
≥1 new syndesmophyte | Male sex (total effect) | 6.51 | 2.71 to 15.6 | <0.001 | 5.12 | 2.26 to 11.6 | <0.001 |
TNFi use prior to X-ray interval | 0.98 | 0.59 to 1.62 | 0.93 | 0.54 | 0.32 to 0.91 | 0.02 | |
Length of the X-ray interval (+ 1 year) | 1.99 | 0.96 to 4.10 | 0.06 | 0.66 | 0.77 to 3.59 | 0.20 |
Results from different multivariable models with spinal radiographic progression defined as an increase of ≥2 mSASSS units in 2 years or as the formation of ≥1 new syndesmophyte in 2 years. Analyses performed in 724 radiographic intervals from 505 patients (59 events in the cervical spine and 64 events in the lumbar spine with progression defined as ≥2 mSASSS units and 62 events in the cervical spine and 69 events in the lumbar spine with progression defined as formation of ≥1 new syndesmophyte). The total effect of sex on radiographic progression includes a direct effect as well as in indirect effect via an impact of baseline spinal radiographic damage.
axSpA, axial spondyloarthritis; mSASSS, Modified Stoke Ankylosing Spondylitis Spinal Score; TNFi, tumour necrosis factor inhibitor.